Key Points

• Successful US healthcare, financial services, and acquisition-company offerings shift institutional capital toward sectors demonstrating stronger fundraising momentum.
• Mixed aftermarket performance signals weakening demand for selected issuers while higher-growth companies continue attracting significant investor interest.
• Limited activity across Europe and Asia reopens the IPO window primarily for US-listed companies as global issuance remains uneven.

US Issuance Activity Continues to Anchor the Global IPO Market

During the week of June 15–June 19, 2026, global IPO activity remained concentrated in the United States as Europe and Asia recorded limited measurable issuance momentum. Institutional investors continued allocating capital selectively toward healthcare, financial services, acquisition companies, and specialized investment vehicles. Several operating-company IPOs successfully entered public markets, producing a mix of positive and negative aftermarket performance. At the same time, the US pipeline remained active with numerous ETF launches, acquisition structures, and newly announced offerings. The week’s activity reinforced the continuing dominance of US capital markets in a global IPO environment characterized by selective risk-taking and limited international participation.

United States — Healthcare and Financial Services Listings Lead New Issuance

The United States accounted for the vast majority of IPO activity during the week. Yorkville International Capital Corp. Units (YICCU) completed a $200.0 million offering priced at $10.00 and later traded at $10.08, while Cantor Equity Partners VII, Inc. (CAES) raised $250.0 million at $10.00 and traded at $10.11. First Carolina Financial Services, Inc. (FCBM) completed a $68.8 million NYSE offering priced at $12.50 before trading at $12.60. The strongest aftermarket performance came from Kardigan, Inc. (KARD), which raised $373.3 million at $16.00 and later traded at $22.00, reflecting substantial investor demand for selected healthcare-related issuers.

Additional activity included Texas Ventures Acquisition IV Corp Units (TVIVU), Wilco 63 Corporation Units (WLCOU), Deep Fission, Inc. (FISN), and MetaOptics (MOT). Deep Fission raised $45.0 million at $16.00 but later traded at $14.56, highlighting the selective nature of investor appetite. The issuance pipeline remained active with new filings involving Honeywell Aerospace, BitMine Immersion Technologies, Churchill Capital Corp XII, Nova Minerals, Irenic Acquisition Corp., Plutonian Acquisition Corp II, multiple Fidelity and J.P. Morgan ETF products, and several Nasdaq-listed investment vehicles. No confirmed withdrawn IPOs or notable lock-up expiration activity were identified during the week.

Europe — Issuance Pipeline Remains Quiet Amid Cautious Conditions

European IPO markets remained largely inactive during the reporting period. No significant confirmed listings, major IPO announcements, or withdrawn offerings were identified across the London Stock Exchange, Euronext, Deutsche Börse, or SIX Swiss Exchange from the reviewed sources. Compared with the pace of US issuance, European fundraising activity remained notably subdued.

The limited activity suggests that issuers continue prioritizing valuation discipline and market timing considerations before pursuing public offerings. Institutional investors likewise remained selective, favoring larger and more liquid opportunities in markets demonstrating stronger issuance momentum. As a result, Europe continued to contribute only marginally to global IPO volumes during the week, reinforcing the concentration of activity in the United States.

Asia — Regional IPO Activity Remains Restrained

Asian IPO markets recorded limited measurable activity during the week, with no significant new listings or major regulatory developments identified across Hong Kong, Tokyo, Shanghai, Shenzhen, Singapore, India, or other major regional exchanges. The absence of notable transactions indicated that companies throughout the region continued adopting a cautious approach toward public fundraising.

Market participants remained sensitive to valuation conditions, investor risk appetite, and broader macroeconomic uncertainty affecting capital flows. While selected companies may continue preparing future listings, the available data showed little evidence of a broad reopening of Asian IPO markets. Consequently, regional issuance activity remained significantly below US levels, where both operating companies and acquisition-focused issuers continued accessing public capital markets.

Markets Will Monitor Whether Healthcare Strength Expands Across the IPO Pipeline

Institutional investors are expected to watch whether the strong aftermarket performance of companies such as Kardigan encourages additional healthcare and biotechnology issuers to accelerate listing plans. Attention will also remain focused on the growing pipeline of acquisition companies, ETF-related products, and specialized investment vehicles scheduled for future pricing. Market participants will monitor whether Europe and Asia generate stronger issuance momentum in coming weeks. Any increase in international IPO activity would provide an important indication that the current recovery in global primary issuance markets is becoming more geographically diversified.